These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8093542)

  • 41. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
    Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
    Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Universal presence of HBVx gene and its close association with hotspot mutation of p53 gene in hepatocellular carcinoma of prevalent area in China].
    Zhang F; Zhu Y; Sun Z
    Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):18-21. PubMed ID: 10921048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
    Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC
    Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TP53 and hepatocellular carcinoma.
    Puisieux A; Ozturk M
    Pathol Biol (Paris); 1997 Dec; 45(10):864-70. PubMed ID: 9769950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Significance of p33(ING1b) and p53 gene expression in hepatocellular carcinoma].
    Zhu Z; Zhu M; Ni C
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1332-6. PubMed ID: 12509938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The epidemiology of hepatocellular carcinoma.
    Johnson PJ
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):845-9. PubMed ID: 8889448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis.
    Kasai Y; Takeda S; Takagi H
    Semin Surg Oncol; 1996; 12(3):155-9. PubMed ID: 8727603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Global epidemiology of hepatocellular carcinoma].
    Kiyosawa K; Sodeyama T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():13-9. PubMed ID: 11761928
    [No Abstract]   [Full Text] [Related]  

  • 49. Genetic heterogeneity of hepatocellular carcinoma.
    Unsal H; Yakicier C; Marçais C; Kew M; Volkmann M; Zentgraf H; Isselbacher KJ; Ozturk M
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):822-6. PubMed ID: 8290606
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Detection of p53 gene mutations in hepatocellular carcinoma].
    Zhou F; Wang J; Lei B; Zhao L; Tang H; Wang X; Zhang X; Li F
    Hua Xi Yi Ke Da Xue Xue Bao; 1997 Mar; 28(1):50-4. PubMed ID: 10684062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [p53 gene mutation in hepatocellular carcinoma].
    Jiang W; Lu Q; Pan G
    Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic changes and histopathological grades in human hepatocellular carcinomas.
    Konishi M; Kikuchi-Yanoshita R; Tanaka K; Sato C; Tsuruta K; Maeda Y; Koike M; Tanaka S; Nakamura Y; Hattori N
    Jpn J Cancer Res; 1993 Aug; 84(8):893-9. PubMed ID: 8407553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Absence of TP53 codon 249 mutations in young Guinean children with high aflatoxin exposure.
    Turner PC; Sylla A; Kuang SY; Marchant CL; Diallo MS; Hall AJ; Groopman JD; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2053-5. PubMed ID: 16103461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is the p53 gene mutation of prognostic value in hepatocellular carcinoma?
    Ng IO; Fan ST
    Arch Surg; 2000 Dec; 135(12):1476. PubMed ID: 11115355
    [No Abstract]   [Full Text] [Related]  

  • 55. Hepatocellular carcinoma and liver cirrhosis TP53 mutation analysis reflects a moderate dietary exposure to aflatoxins in Espírito Santo State, Brazil.
    de Carvalho FM; de Almeida Pereira T; Gonçalves PL; Jarske RD; Pereira FE; Louro ID
    Mol Biol Rep; 2013 Aug; 40(8):4883-7. PubMed ID: 23649769
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular aspects of hepatic carcinogenesis.
    Nita ME; Alves VA; Carrilho FJ; Ono-Nita SK; Mello ES; Gama-Rodrigues JJ
    Rev Inst Med Trop Sao Paulo; 2002; 44(1):39-48. PubMed ID: 11896411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver cancer in low and middle income countries.
    Hall AJ; Wild CP
    BMJ; 2003 May; 326(7397):994-5. PubMed ID: 12742895
    [No Abstract]   [Full Text] [Related]  

  • 58. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
    Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS
    Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
    Jayshree RS; Sridhar H
    Cancer; 2000 Dec; 89(11):2322-3. PubMed ID: 11147604
    [No Abstract]   [Full Text] [Related]  

  • 60. [Hepatocarcinoma, liver cirrhosis and the HBV].
    Núñez-Cortés JM
    Rev Clin Esp; 1993 Apr; 192(7):305-7. PubMed ID: 8388573
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.